Modeling the long-range effect of an inversion downstream of EFNB1 concludes a 43-year molecular diagnostic odyssey for craniofrontonasal syndrome
Open Access
- 9 June 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 33 (12) , 1684-1689
Abstract
Craniofrontonasal syndrome (CFNS; MIM #304110) is a rare craniofacial disorder characterized by hypertelorism, a broad nasal root with a bifid nasal tip, orofacial clefting, and genital malformations caused by pathogenic variants in the X-linked gene EFNB1 (MIM *300035). CFNS exhibits sex-specific heterogeneity, with increased severity in females likely secondary to cellular interference related to random X-inactivation, resulting in mosaic EFNB1 expression. Previous studies have identified over 140 variants in EFNB1 , but approximately 20% of CFNS have negative molecular testing, either due to a yet undiscovered causal gene or causal variants in regulatory regions not covered by traditional genetic testing methodologies. Here, we report a two-generation family with a clinical diagnosis of CFNS and negative clinical molecular testing. Research short-read genome testing identified a 2-Mb inversion together with two smaller deletions (13- and 7-bp), about 106-Kb downstream of EFNB1 , which cosegregated with CFNS. Patient-derived fibroblasts reprogrammed into induced pluripotent stem cells (iPSCs) demonstrated two distinct iPSC populations in affected females, where one or other of the two X chromosomes was inactivated. In vitro assays further demonstrated that iPSCs with the active X chromosome bearing the inversion, exhibited a significant increase in EFNB1 expression, suggesting allelic imbalance contributes to mosaic EFNB1 expression. These findings nominate a novel causal variant type of CFNS, conclude a 43-year diagnostic odyssey for an affected family, and offer new hope for family planning for affected individuals.Keywords
This publication has 35 references indexed in Scilit:
- Utility of genome sequencing in exome‐negative pediatric patients with neurodevelopmental phenotypesAmerican Journal of Medical Genetics Part A, 2024
- The impact of inversions across 33,924 families with rare disease from a national genome sequencing projectThe American Journal of Human Genetics, 2024
- Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomaliesThe American Journal of Human Genetics, 2023
- Disentangling the paradox of the PCDH19 clustering epilepsy, a disorder of cellular mosaicsCurrent Opinion in Genetics & Development, 2020
- CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter FunctionCell, 2015
- PCDH19-related infantile epileptic encephalopathy: An unusual X-linked inheritance disorderHuman Mutation, 2012
- Xq12q13.1 microduplication encompassing the EFNB1 gene in a boy with congenital diaphragmatic herniaEuropean Journal of Medical Genetics, 2011
- Duplication of the EFNB1 gene in familial hypertelorism: imbalance in ephrin‐B1 expression and abnormal phenotypes in humans and miceHuman Mutation, 2011
- Additional EFNB1 mutations in craniofrontonasal syndromeAmerican Journal of Medical Genetics Part A, 2008
- Twenty-six novelEFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS)Human Mutation, 2005